A study by Peterson et al[23] showed that a HER2 monoclonal antibody (MA 7.16.4) was more effective in inhibiting cell growth in the presence of tamoxifen in a radiation-induced breast tumor model. Here, ERBB2 is linked to breast neoplasm.